You have 9 free searches left this month | for more free features.

City

Condition

Secondary Hyperparathyroidism (2)

End Stage Kidney Disease (1)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 3 (2)

Sponsor

Pathalys Pharma (2)

Collaborator

Launch Therapeutics (2)

Intervention

open-label extension pls240 (2)

placebo (2)

pls240 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

pls240

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Secondary Hyperparathyroidism Trial (PLS240, Placebo, Open-Label Extension PLS240)

Not yet recruiting

Secondary Hyperparathyroidism

PLS240
+2 more

(no location specified)

Apr 17, 2023

Secondary Hyperparathyroidism, End Stage Kidney Disease Trial (PLS240, Placebo, Open-Label Extension PLS240)

Not yet recruiting

Secondary Hyperparathyroidism
End Stage Kidney Disease

PLS240
+2 more

(no location specified)

Apr 18, 2023